Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.
Get Details: These 3 Stocks are the Dark Horses of the Stock Market
SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
---|---|---|---|---|
AARTI DRUGS | 699.25 -0.44% | 699.15 -0.43% |
|
More Info ![]() |
AJANTA PHARMA | 1,776.25 -0.98% | 1,778.75 -0.98% |
|
More Info ![]() |
ALEMBIC PHARMA | 979.75 -4.87% | 980.05 -4.91% |
|
More Info ![]() |
BIOCON | 449.70 -0.44% | 449.80 -0.40% |
|
More Info ![]() |
CADILA HEALTHCARE | 485.95 0.11% | 486.20 0.21% |
|
More Info ![]() |
CIPLA | 832.60 1.25% | 832.80 1.26% |
|
More Info ![]() |
DIVIS LABORATORIES | 3,604.95 0.10% | 3,605.70 0.17% |
|
More Info ![]() |
DR. REDDYS LAB | 5,078.65 -0.16% | 5,080.65 -0.16% |
|
More Info ![]() |
GLENMARK PHARMA | 508.85 0.87% | 509.00 0.92% |
|
More Info ![]() |
INDOCO REMEDIES | 322.90 -1.07% | 322.70 -1.06% |
|
More Info ![]() |
IPCA LABS | 2,104.15 -0.92% | 2,102.30 -1.23% |
|
More Info ![]() |
J.B.CHEMICALS | 998.05 -1.70% | 999.00 -1.92% |
|
More Info ![]() |
LUPIN | 1,087.45 -0.25% | 1,088.50 -0.06% |
|
More Info ![]() |
NATCO PHARMA | 905.35 -0.49% | 906.00 -0.50% |
|
More Info ![]() |
NIFTY 50 | Not Listed | 14,644.70 0.85% |
|
More Info ![]() |
ORCHID PHARMA | 249.30 4.99% | 18.90 -2.83% |
|
More Info ![]() |
PANACEA BIOTECH | 210.50 -1.01% | 210.30 -1.08% |
|
More Info ![]() |
PIRAMAL ENTERPRISES | 1,596.40 0.37% | 1,596.25 0.30% |
|
More Info ![]() |
S&P BSE HEALTHCARE | 21,883.29 0.13% | Not Listed |
|
More Info ![]() |
S&P BSE SENSEX | 49,792.12 0.80% | Not Listed |
|
More Info ![]() |
STRIDES PHARMA SCIENCE | 891.85 -1.70% | 892.55 -1.67% |
|
More Info ![]() |
SUN PHARMA | 594.45 -0.30% | 594.70 -0.31% |
|
More Info ![]() |
TORRENT PHARMA | 2,722.60 -1.01% | 2,722.15 -1.05% |
|
More Info ![]() |
WOCKHARDT | 534.75 1.37% | 535.35 1.57% |
|
More Info ![]() |
BSE prices: January 20, 2021 (Close) NSE prices: January 20, 2021 (Close)
The NIFTY PHARMA Index was at 12,875.6 (up 0.1%). The index is up 25.0% over the last 30 days. And over the last 1 year, it has gained 37.1%.
Within the Indian Pharma sector, the top gainers were ORCHID PHARMA (up 5.0%) and WOCKHARDT (up 1.4%). On the other hand, ALEMBIC PHARMA (down 4.9%) and STRIDES PHARMA SCIENCE (down 1.7%) were among the top losers.
Meanwhile, the benchmark NIFTY 50 was at 14,644.7 (up 0.9%).
What else is happening in the markets today? Dig in...
Indian share markets extended gains to the second day today and ended at record-high levels with Nifty ending above 14,600-mark.
ALEMBIC PHARMA share price is trading down by 5% and its current market price is Rs 1,041. The BSE HEALTHCARE is up by 0.1%. The top gainers in the BSE HEALTHCARE Index are SHILPA MEDICARE (up 2.9%) and LAURUS LABS (up 2.4%). The top losers is ALEMBIC PHARMA (down 5.1%).
WOCKHARDT share price is trading up by 5% and its current market price is Rs 557. The BSE HEALTHCARE is up by 0.2%. The top gainers in the BSE HEALTHCARE Index is WOCKHARDT (up 5.3%). The top losers are LUPIN and GRANULES INDIA .
For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
More Views on NewsThe smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Our ace stock picker is ready to capitalise on a big growth opportunity.
More